CCL19



CCL19

G1GG1T2TT2N3NN3D4DD4A5AA5E6EE6D7DD7C8CC8C9CC9L10LL10S11SS11V12VV12T13TT13Q14QQ14K15KK15P16PP16I17II17P18PP18G19GG19Y20YY20I21II21V22VV22R23RR23N24NN24F25FF25H26HH26Y27YY27L28LL28L29LL29I30II30K31KK31D32DD32G33GG33C34CC34R35RR35V36VV36P37PP37A38AA38V39VV39V40VV40F41FF41T42TT42T43TT43L44LL44R45RR45G46GG46R47RR47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence GTNDAEDCCLSVTQKPIPGYIVRNFHYLLIKDGCRVPAVVFTTLRGRQLCAPPDQPWVERIIQRLQRTSAKMKRRSS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

CCL19

G1GG1T2TT2N3NN3D4DD4A5AA5E6EE6D7DD7C8CC8C9CC9L10LL10S11SS11V12VV12T13TT13Q14QQ14K15KK15P16PP16I17II17P18PP18G19GG19Y20YY20I21II21V22VV22R23RR23N24NN24F25FF25H26HH26Y27YY27L28LL28L29LL29I30II30K31KK31D32DD32G33GG33C34CC34R35RR35V36VV36P37PP37A38AA38V39VV39V40VV40F41FF41T42TT42T43TT43L44LL44R45RR45G46GG46R47RR47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.